UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 6,476	$ 5,586
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	298	301
Amortization	1,179	1,259
Provision for (recovery of) losses on accounts receivable	(7)	(9)
(Gain) loss on disposal of assets	0	1
Deferred income taxes	(237)	(213)
Stock-based compensation expense	42	44
Changes in operating assets and liabilities:
Accounts receivable	(450)	(828)
Accrued interest and other receivables	(34)	(81)
Inventories	196	218
Prepaid expenses and other current assets	61	104
Accounts payable	427	5
Accrued expenses	(222)	(654)
Total adjustments	1,253	147
Net cash provided by operating activities	7,729	5,733
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(90)	(109)
Capital expenditures for intangible assets	(9)	(7)
Net cash provided by (used in) investing activities	(99)	(116)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	257	245
Common stock purchased and retired	0	(215)
Payment of taxes for exchange of stock options	0	(42)
Tax benefit attributable to exercise of stock options	35	107
Repayment of notes payable	0	(4,778)
Payment of dividends	(976)	(957)
Net cash provided by (used in) financing activities	(684)	(5,640)
Effect of exchange rate changes on cash	(829)	(82)
Net increase (decrease) in cash and cash equivalents	6,117	(105)
Cash at beginning of period	23,278	19,274
Cash at end of period	29,395	19,169
Cash paid during the period for income taxes	2,422	2,781
Cash paid during the period for interest	$ 0	$ 65